Page 1040 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 5

133. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. 150. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ,
A comparison of albumin and saline for fluid resuscitation in Watson D. Elevation of systemic oxygen delivery in the treatment
the intensive care unit. N Engl J Med. 2004;350(22):2247-2256. of critically ill patients. N Engl J Med. 1994;330(24):1717-1722.
134. Kirchheim HR, Ehmke H, Hackenthal E, Lowe W, Persson P. 151. Jardin F, Sportiche M, Bazin M, Bourokba A, Margairaz A.
Autoregulation of renal blood flow, glomerular filtration rate Dobutamine: a hemodynamic evaluation in human septic
and renin release in conscious dogs. Pflugers Arch. 1987; shock. Crit Care Med. 1981;9(4):329-332.
410(4-5):441-449. 152. Tell B, Majerus TC, Flancbaum L. Dobutamine in elderly septic
135. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfu- shock patients refractory to dopamine. Intensive Care Med.
sion pressure on tissue perfusion in septic shock. Crit Care Med. 1987;13(1):14-18.
2000;28(8):2729-2732. 153. Vincent JL, Roman A, Kahn RJ. Dobutamine administration in
136. Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C. septic shock: addition to a standard protocol. Crit Care Med.
Increasing mean arterial pressure in patients with septic shock: 1990;18(7):689-693.
effects on oxygen variables and renal function. Crit Care Med. 154. Loop T, Bross T, Humar M, et al. Dobutamine inhibits phorbol-
2005;33(4):780-786. myristate-acetate-induced activation of nuclear factor-
137. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine kappaB in human T lymphocytes in vitro. Anesth Analg. 2004;
or dopamine for the treatment of hyperdynamic septic shock? 99(5):1508-1515.
Chest. 1993;103(6):1826-1831. 155. Barton P, Garcia J, Kouatli A, et al. Hemodynamic effects of
138. Martin C, Viviand X, Leone M, Thirion X. Effect of norepi- i.v. milrinone lactate in pediatric patients with septic shock.
nephrine on the outcome of septic shock. Crit Care Med. A prospective, double-blinded, randomized, placebo-controlled,
2000;28(8):2758-2765. interventional study. Chest. 1996;109(5):1302-1312.
139. De BD, Biston P, Devriendt J, et al. Comparison of dopamine 156. Heinz G, Geppert A, Delle KG, et al. IV milrinone for cardiac
and norepinephrine in the treatment of shock. N Engl J Med. output increase and maintenance: comparison in nonhyperdy-
2010;362(9):779-789. namic SIRS/sepsis and congestive heart failure. Intensive Care
Med. 1999;25(6):620-624.
140. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor
hypersensitivity in vasodilatory septic shock. Crit Care Med. 157. Barraud D, Faivre V, Damy T, et al. Levosimendan restores both
1997;25(8):1279-1282. systolic and diastolic cardiac performance in lipopolysaccharide-
treated rabbits: comparison with dobutamine and milrinone.
141. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency Crit Care Med. 2007;35(5):1376-1382.
contributes to the vasodilation of septic shock. Circulation.
1997;95(5):1122-1125. 158. Cunha-Goncalves D, Perez-de-Sa V, Dahm P, Grins E, Thorne J,
Blomquist S. Cardiovascular effects of levosimendan in the early
142. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. stages of endotoxemia. Shock. 2007;28(1):71-77.
The effects of vasopressin on hemodynamics and renal func- 159. Faivre V, Kaskos H, Callebert J, et al. Cardiac and renal
tion in severe septic shock: a case series. Intensive Care Med. effects of levosimendan, arginine vasopressin, and norepi-
2001;27(8):1416-1421.
nephrine in lipopolysaccharide-treated rabbits. Anesthesiology.
143. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low- 2005;103(3):514-521.
dose vasopressin in the treatment of vasodilatory septic shock. 160. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P,
J Trauma. 1999;47(4):699-703. Wanecek M. Effects of levosimendan, a novel inotropic calcium-
144. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects sensitizing drug, in experimental septic shock. Crit Care Med.
of short-term vasopressin infusion during severe septic shock. 2001;29(11):2185-2193.
Anesthesiology. 2002;96(3):576-582. 161. Morelli A, De Castro S, Teboul JL, et al. Effects of levosimendan
145. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepi- on systemic and regional hemodynamics in septic myocardial
nephrine infusion in patients with septic shock. N Engl J Med. depression. Intensive Care Med. 2005;31(5):638-644.
2008;358(9):877-887. 162. Morelli A, Teboul JL, Maggiore SM, et al. Effects of levosi-
146. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE. Right mendan on right ventricular afterload in patients with acute
ventricular dysfunction and dilatation, similar to left ventricular respiratory distress syndrome: a pilot study. Crit Care Med.
changes, characterize the cardiac depression of septic shock in 2006;34(9):2287-2293.
humans. Chest. 1990;97(1):126-131. 163. Alhashemi JA, Alotaibi QA, Abdullah GM, Shalabi SA.
147. Vincent JL, Reuse C, Frank N, Contempre B, Kahn RJ. Levosimendan vs dobutamine in septic shock. J Crit Care.
Right ventricular dysfunction in septic shock: assessment 2009;24(3):e14-e15.
by measurements of right ventricular ejection fraction using 164. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y.
the thermodilution technique. Acta Anaesthesiol Scand. Corticosteroids for severe sepsis and septic shock: a systematic
1989;33(1):34-38. review and meta-analysis. BMJ. 2004;329(7464):480.
148. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac 165. Bone RC, Fisher CJ Jr., Clemmer TP, Slotman GJ, Metz CA,
dysfunction. Crit Care Med. 2007;35(6):1599-1608. Balk RA. A controlled clinical trial of high-dose methylpred-
149. Silverman HJ, Penaranda R, Orens JB, Lee NH. Impaired nisolone in the treatment of severe sepsis and septic shock.
beta-adrenergic receptor stimulation of cyclic adenosine N Engl J Med. 1987;317(11):653-658.
monophosphate in human septic shock: association with myo- 166. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for
cardial hyporesponsiveness to catecholamines. Crit Care Med. sepsis: a critical appraisal and meta-analysis of the literature.
1993;21(1):31-39. Crit Care Med. 1995;23(8):1430-1439.

Section05-O-ref.indd 5 1/20/2015 4:51:17 PM